Foundation Fighting Blindness Announces Leadership Changes
ncarol.com/10178661

Jason Menzo named chief executive officer

Russell Kelley, PhD, MBA, appointed managing director of the RD Fund

Ben Yerxa, PhD, to lead Opus Genetics, the first RD Fund- and Foundation-backed spin-off company

COLUMBIA, Md., June 21, 2022 /PRNewswire/ -- The Foundation Fighting Blindness, the world's leading organization committed to finding treatments and cures for blinding retinal diseases, announced today the promotions of Jason Menzo to chief executive officer (CEO) of the Foundation and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration (RD) Fund, the venture arm of the Foundation, effective July 1, 2022. Ben Yerxa, PhD, who has served as CEO of the Foundation since 2017, will be transitioning to assume the permanent CEO position for Opus Genetics, the first spin-off company internally conceived and launched by the RD Fund to further the Foundation's mission.

More on ncarol.com

• Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
• New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript
• Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
• First Flight Society Celebrates National Aviation Day 2026 on Wednesday, August 19th
• Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"

---

Show All News | Disclaimer | Report Violation